Biological variation at long-term renal post-transplantation

Area of Science:

• Clinical Chemistry
• Transplantation Medicine
• Biostatistics

Background:

• Reference change value (RCV) is crucial for detecting early clinical status changes in patients.
• Previous studies established RCVs for creatinine and urate in early post-transplant kidney recipients.
• Long-term biological variation (BV) data is needed to predict crises in stable, long-term transplant patients.

Purpose of the Study:

• To determine BV components for creatinine and urate in long-term kidney transplant recipients.
• To assess if previously established RCVs are applicable to long-term stable transplant patients.
• To evaluate the utility of RCVs for predicting potential crises in this cohort.

Main Methods:

• Calculated BV components for creatinine and urate in 40 long-term post-renal transplant patients (stable 4-7 years).
• Collected an average of 8 samples per patient over 1-2 years.
• Compared BV components and variation metrics (CVI+A) with a short-term post-transplant group.

Main Results:

• No statistically significant differences in within-subject variation or CVI+A for creatinine and urate between short-term and long-term post-transplant groups.
• Comparable distribution of CVI+A values in both patient groups.
• Maintained independence between creatinine and urate levels in the long-term group.

Conclusions:

• Biological variation components for creatinine and urate are similar in both short-term and long-term kidney transplant recipients.
• The RCV established for early post-transplant monitoring is applicable to long-term stable patients.
• Applying these RCVs can optimize laboratory reporting and serve as a valuable tool for clinical decision-making in transplant recipients.